SoCal Myeloma Community Chapter: Minimal Residual Disease (MRD) clonoSEQ Testing- What Is It? How Can It Help You?
SoCal Myeloma Community Chapter: Minimal Residual Disease (MRD) clonoSEQ Testing- What Is It? How Can It Help You? image
Apr 12, 2022 / 06:30PM - 08:00PM PDT
SoCal Myeloma Community Chapter

Event Description

The Southern California Myeloma Community Chapter invites you to join us to learn more about Minimal Residual Disease (MRD) clonoSEQ testing from Adaptive Biotechnologies. Our guest speaker is Mark Schleikelman, Senior Medical Science Liaison with Adaptive Biotechnologies. He will share details about the MRD clonoSEQ test -- what it is, why it is important, and resources you can use to advocate for the inclusion of this important test in your myeloma treatment plan.

Schedule & Agenda

person
Log In - Interactive, Virtual Mingle and Chat
06:25PM
SoCal Community Chapter Members
person
Welcome and Introductions
06:30PM
Audrey Burton-Bethke and Todd Kennedy
person
Getting to Know our SoCal Myeloma Community
06:40PM
Diane Kennedy
In an effort to connect our community, we will hear from one of our chapter members as they share their myeloma story. We will also conduct a short anonymous poll to learn years since diagnoses and disease status of those attending the meeting.
person
Presentation with Q&A: Minimal Residual Disease (MRD) clonoSEQ Testing- What Is It? How Can It Help You?
06:50PM
Mark Schleikelman, Senior Medical Science Liaison, Adaptive Biotechnologies
person
Virtual Mingle
07:45PM
SoCal Community Chapter Members

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Diane Kennedy
Diane Kennedy

Diane has lived in Southern California for most of her life. Her husband Todd was diagnosed with multiple myeloma in 2017. She spent her career working in marketing until January 2020 when she and Todd retired from their respective first careers, to devote their time and talents as patient advocates, Myeloma Crowd coaches, and ambassadors for City of Hope’s expansion to Orange County. She and her husband are committed to helping improve and advance cancer care for all patients and feel a collaborative, virtual support group that draws from this region is an excellent way to help current patients and their families, and future generations of cancer thrivers as well.

Read Bio
The panelist Todd Kennedy
Todd Kennedy

Todd Kennedy is a Myeloma Coach and grateful patient. His background includes over 30 years working in the pharmaceutical industry until he and his wife Diane retired from their respective first careers to devote their time and talents as patient advocates, Myeloma Crowd coaches, and ambassadors for City of Hope’s expansion to Orange County. Todd is living life to the fullest with his wife and sons in Orange County, CA.

Read Bio
The panelist Mark Schliekelman
Mark Schliekelman

Experienced Medical Science Liaison with with deep understanding of Oncology and Pharmaceuticals . Skilled in Scientific Review, Molecular Biology, Biotechnology, Cell Culture, and Scientific Writing. Strong research professional with a Doctor of Philosophy (Ph.D.) focused in Genetics and Molecular Biology from UNC Chapel Hill. I see my role: As identifying engaging and maintaining relationships with Key Opinion Leaders. To be a collaborative and supportive partner with business and research professionals. As a Medical Affairs Facilitator and subject matter expert with a demonstrated ability effectively communicate. To provide information that is clear, concise and clinically relevant. To ask provocative questions that challenge current assumptions. Provide thoughtful answers to queries and concerns. Give peer level support in ensuring well-run research and trials. I consider myself to be a person of integrity; principled, diplomatic, calm, thoughtful and reflective. I have a deep understanding of oncology and am able to go toe to toe with Key Opinion Leaders in an engaging scientific exchange.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811